REGULONIX HOLDING, INC.
Regulonix is an early-stage biotechnology company developing non-opioid drugs for chronic pain. By indirectly targeting the sodium channel NaV1.7 – a well-established and genetically validated pain target – and focusing on the signaling pathways that control this channel’s activity, the Regulonix team has isolated compounds demonstrated in animal models to be non-addictive and more effective than morphine. This unique platform helps address a global pain management therapeutics market projected to reach $83B by 2024, affecting more than 100 million Americans and 1.5 billion people globally.
REGULONIX HOLDING, INC.
Social Links:
Industry:
Biopharma Biotechnology Pharmaceutical
Founded:
2018-01-01
Address:
Tucson, Arizona, United States
Country:
United States
Website Url:
http://www.regulonix.com
Total Employee:
1+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
2 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SSL By Default Google Font API Google Analytics Apple Mobile Web Clips Icon Google Tag Manager WordPress Google Universal Analytics Font Awesome
Similar Organizations
Day One Biopharmaceuticals
Day One Biopharmaceuticals is a biotechnology company that focuses on developing new cancer therapies for patients of all ages.
Immunome
Immunome is a biotechnology company that specializes in immunotherapy, biotechnology, and antigen discovery.
KSQ Therapeutics
KSQ Therapeutics is using CRISPR technology within a powerful drug discovery engine to enable high-confidence drug development.
NephroDI Therapeutics
NephroDI Therapeutics is a biopharmaceutical company that focuses on the concentration disorders of the kidney.
OncoHost
OncoHost is a clinical-stage biotechnology company developing personalized strategies to increase the success of cancer therapy.
Reata Pharmaceuticals
Reata Pharmaceuticals is a biopharmaceutical company that develops drugs for cancer, inflammation, and neurodegenerative diseases.
Current Advisors List
Current Employees Featured
Founder
Investors List
Desert Angels
Desert Angels investment in Seed Round - Regulonix Holding, Inc.
UAVenture Capital
UAVenture Capital investment in Seed Round - Regulonix Holding, Inc.
Official Site Inspections
http://www.regulonix.com
- Host name: ec2-54-243-117-197.compute-1.amazonaws.com
- IP address: 54.243.117.197
- Location: Ashburn United States
- Latitude: 39.0481
- Longitude: -77.4728
- Metro Code: 511
- Timezone: America/New_York
- Postal: 20149
More informations about "Regulonix Holding, Inc."
A game-changing solution - Regulonix
Regulonix was founded to address the growing opioid epidemic. Our science approaches the issue of treating pain in an entirely new way that is targeted and highly selective, resulting in non-addictive solutions.See details»
Regulonix Holding, Inc. - Crunchbase Company Profile & Funding
Regulonix is an early-stage biotechnology company developing non-opioid drugs for chronic pain. By indirectly targeting the sodium channel NaV1.7 – a well-established and genetically …See details»
Regulonix Holding, Inc. | LinkedIn
Regulonix is an early-stage biotechnology company developing non-opioid drugs for chronic pain. By indirectly targeting the sodium channel NaV1.7 – a well-established and genetically validated ...See details»
Regulonix 2025 Company Profile: Valuation, Funding & Investors
Regulonix General Information Description. Developer of a non-opioid therapeutic drug designed to provide relief from chronic pain. The company's drug targets the genetically validated pain …See details»
Regulonix Company Profile - Office Locations, Competitors ... - Craft
Regulonix is a biotechnology company developing non-opioid drugs for chronic pain. Its technology targets genetically validated pain NaV1.7 sodium channel and focuses on the …See details»
Regulonix Company Profile | Management and Employees List
Regulonix Profile and History. Regulonix is an early-stage biotechnology company developing non-opioid drugs for chronic pain. By indirectly targeting the sodium channel NaV1.7 a well …See details»
Focusing on a validated biologic pain target with a unique
Regulonix is an early-stage biotechnology company developing non-opioid therapeutics that relieve chronic pain. By indirectly targeting the well-established and genetically validated pain …See details»
Regulonix Holding, Inc. - Funding, Financials, Valuation & Investors
Regulonix is a biotechnology company that develops non-opioid drugs for chronic pain. New. Resources. Advanced Search. Start Free Trial . Talk With Sales. Pricing. Log In. Log In. …See details»
Regulonix - VentureRadar
Regulonix was founded to address the growing opioid epidemic. Our science approaches the issue of treating pain in an entirely new way that is targeted and highly selective, resulting in …See details»
Regulonix Holding, Inc. - Crunchbase
Regulonix is a biotechnology company that develops non-opioid drugs for chronic pain.See details»
Regulonix, LLC Company Profile | Tucson, AZ - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for Regulonix, LLC of Tucson, AZ. Get the latest business insights from Dun & Bradstreet.See details»
News - Regulonix
Press Releases July, 2018 Non-opioid pain therapeutics company Regulonix Raises $2 Million in Seed Funding Led by UAVenture Capital Fund Regulonix Holding, Inc., a University of Arizona …See details»
Regulonix Holding - Org Chart, Teams, Culture & Jobs - The Org
Regulonix is an early-stage biotechnology company developing non-opioid drugs for chronic pain. By indirectly targeting the sodium channel NaV1.7 – a well-established and genetically …See details»
Regulonix, LLC - Tech Launch Arizona
Regulonix, LLC Life Sciences. Regulonix, LLC. Year. 2018. Regulonix is developing non-opioid-based small molecule inhibitors for chronic pain reduction. These molecules indirectly regulate …See details»
Compound Developed at UArizona Health Sciences Provides …
Nov 9, 2021 Entrepreneurial UArizona researchers have made a significant breakthrough on a safe and effective non-opioid pain reliever. The prestigious medical journal, Science …See details»
Regulonix Holding, Inc. - Contacts, Employees, Board ... - Crunchbase
Regulonix Holding, Inc. has 2 current employee profiles, including Chief Scientific Officer Rajesh Khanna. Regulonix Holding, Inc. has 1 board member or advisor, Fletcher J. McCusker . …See details»
Non-opioid pain therapeutics company Regulonix Raises $2 …
Jul 10, 2018 Regulonix will use the proceeds to fund several preclinical development milestones of its internationally patented lead compounds, demonstrated in animal models to be non …See details»
Regulonix - UA Venture Capital
Regulonix is an early-stage biotechnology company developing non-opioid therapeutics that relieve chronic pain. By indirectly targeting the well-established and genetically validated pain …See details»
Startup Regulonix pursues non-opioid pain drug that indirectly …
Nov 10, 2021 The University of Arizona has licensed the drug, dubbed 194, to a startup called Regulonix, which was co-founded by the study’s senior author, Rajesh Khanna, Ph.D., to …See details»
Non-opioid pain therapeutics company Regulonix Raises $2
Jul 10, 2018 Regulonix to use proceeds for advancing drug candidates toward human clinical trials Patented lead compounds demonstrated in animal models to be non-addictive and more …See details»